AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion Biotech Health services Investments 19 October 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 141M Round investors: Longwood FundForbion Capital PartnersAthos CapitalSchrodersAmgenColumbia IMCXGEN VentureSixty Degree CapitalNeva SGRCDP Venture Capital SgrSofinnova PartnersAtlas Venture Company: AAVantgarde Bio Industry: BiotechHealth services
Tubulis in germany was acquired by Nasdaq-listed Gilead Sciences for $5 billion, $315B upfront, plus up to $1.85B in contingent milestone payments. Biotech Health services M&A 01 April 2026
Exein raised €100m series D led by Blue Cloud Ventures, joined by HV Capital, Intrepid Growth Partners, Geodesic Capital, and JPMorgan. Security Software Services Investments 06 December 2025
Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare. Biotech Health services Investments 19 November 2025